"Medical Oncology Hematology Consultants, PA is Delaware's largest cancer care center, providing high-quality, evidence-based cancer care and expertise in the diagnsis and treatment of cancers and disorders of the blood."

During the past decade, Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" are "MSS" (1 trials), "Prostatic Neoplasms, Castration-Resistant" (1 trials) and "RAS-mutant Colorectal Cancer" (1 trials). Many other conditions were trialed in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" in a lesser frequency.

Most popular intervention types in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS-986218" (1 trials), "Docetaxel" (1 trials), "Nivolumab" (1 trials), "binimetinib" (1 trials) and "ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical oncology Hematology Consultants PA, Helen F Graham Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".